Active Clearance of Chest Tubes Reduces Re-Exploration for Bleeding After Ventricular Assist Device Implantation

Simon Maltais, Mary E Davis, Nicholas A Haglund, Louis Perrault, Sudhir S Kushwaha, John M Stulak, Edward M Boyle, Simon Maltais, Mary E Davis, Nicholas A Haglund, Louis Perrault, Sudhir S Kushwaha, John M Stulak, Edward M Boyle

Abstract

Chest tubes are utilized to evacuate shed blood after left ventricular assist device (LVAD) implantation, however, they can become clogged, leading to retained blood. We implemented a protocol for active tube clearance (ATC) of chest tubes to determine if this might reduce interventions for retained blood. A total of 252 patients underwent LVAD implantation. Seventy-seven patients had conventional chest tube drainage (group 1), whereas 175 patients had ATC (group 2). A univariate and multivariate analysis adjusting for the use of conventional sternotomy (CS) and minimally invasive left thoracotomy (MILT) was performed. Univariate analysis revealed a 65% reduction in re-exploration (43-15%, p < 0.001), and an 82% reduction in delayed sternal closure (DSC; 34-6%, p <0.001). In a sub-analysis of CS only, there continued to be statistically significant 53% reduction in re-exploration (45% vs. 21%, p = 0.0011), and a 77% reduction in DSC (35% vs. 8%, p < 0.001) in group 2. Using a logistic regression model adjusting for CS versus MILT, there was a significant reduction in re-exploration (odds ratio [OR] = 0.44 [confidence interval {CI} = 0.23-0.85], p = 0.014) and DSC (OR = 0.20 [CI = 0.08-0.46], p <0.001) in group 2. Actively maintaining chest tube patency after LVAD implantation significantly reduces re-exploration and DSC.

Trial registration: ClinicalTrials.gov NCT02145858.

References

    1. Miller LW, Pagani FD, Russell SD, et al. HeartMate II Clinical Investigators. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896.
    1. Slaughter MS. Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res. 2010;3:618–624.
    1. Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263–9; discussion 1269.
    1. Schaffer JM, Arnaoutakis GJ, Allen JG, et al. Bleeding complications and blood product utilization with left ventricular assist device implantation. Ann Thorac Surg. 2011;91:740–7; discussion 747.
    1. Slaughter MS, Rogers JG, Milano CA, et al. HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–2251.
    1. Haglund NA, Davis ME, Tricarico NM, et al. Perioperative blood product use: A comparison between HeartWare and HeartMate II devices. Ann Thorac Surg. 2014;98:842–849.
    1. Karimov JH, Gillinov AM, Schenck L, et al. Incidence of chest tube clogging after cardiac surgery: A single-centre prospective observational study. Eur J Cardiothorac Surg. 2013;44:1029–1036.
    1. Boyle EM, Jr, Gillinov AM, Cohn WE, Ley SJ, Fischlein T, Perrault LP. Retained blood syndrome after cardiac surgery: A new look at an old problem. Innovations (Phila) 2015;10:296–303.
    1. Day TG, Perring RR, Gofton K. Is manipulation of mediastinal chest drains useful or harmful after cardiac surgery? Interact Cardiovasc Thorac Surg. 2008;7:888–890.
    1. Arakawa Y, Shiose A, Takaseya T, et al. Superior chest drainage with an active tube clearance system: Evaluation of a downsized chest tube. Ann Thorac Surg. 2011;91:580–583.
    1. Shiose A, Takaseya T, Fumoto H, et al. Improved drainage with active chest tube clearance. Interact Cardiovasc Thorac Surg. 2010;10:685–688.
    1. Sirch J, Ledwon M, Püski T, Boyle EM, Pfeiffer S, Fischlein T. Active clearance of chest drainage catheters reduces retained blood. J Thorac Cardiovasc Surg. 2016;151:832–8.e1.
    1. Maltais S, Davis ME, Haglund N. Minimally invasive and alternative approaches for long-term LVAD placement: The Vanderbilt strategy. Ann Cardiothorac Surg. 2014;3:563–569.
    1. Wagner CE, Bick JS, Kennedy J, et al. Minimally invasive thoracic left ventricular assist device implantation; case series demonstrating an integrated multidisciplinary strategy. J Cardiothorac Vasc Anesth. 2015;29:271–274.
    1. Shalli S, Boyle EM, Saeed D, Fukamachi K, Cohn WE, Gillinov AM. The active tube clearance system: A novel bedside chest-tube clearance device. Innovations (Phila) 2010;5:42–47.
    1. Vistarini N, Gabrysz-Forget F, Beaulieu Y, Perrault LP. Tamponade relief by active clearance of chest tubes. Ann Thorac Surg. 2016;101:1159–1163.
    1. Perrault LP, Pellerin M, Carrier M, et al. The PleuraFlow Active Chest Tube Clearance System: Initial clinical experience in adult cardiac surgery. Innovations (Phila) 2012;7:354–358.
    1. Stulak JM, Romans T, Cowger J, et al. Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation. J Heart Lung Transplant. 2012;31:1115–1119.
    1. Labidi M, Baillot R, Dionne B, Lacasse Y, Maltais F, Boulet LP. Pleural effusions following cardiac surgery: Prevalence, risk factors, and clinical features. Chest. 2009;136:1604–1611.
    1. Guha A, Munjampalli S, Bandi V, Loebe M, Noon G, Lunn W. Pleural effusion after ventricular assist device placement: Prevalence and pleural fluid characteristics. Chest. 2008;134:382–386.
    1. Sileshi B, Haglund NA, Davis ME, et al. In-hospital outcomes of a minimally invasive off-pump left thoracotomy approach using a centrifugal continuous-flow left ventricular assist device. J Heart Lung Transplant. 2015;34:107–112.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner